PMA supplement
P950005 S013: CELSIUS II BIDIRECTIONAL DEFLECTING DIAGNOSTIC/ABLATION CATHETER
FDA PMA supplement · Real-Time Process · Biosense Webster, Inc.
Key facts
| Original PMA | P950005 |
|---|---|
| Supplement number | S013 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | CELSIUS II BIDIRECTIONAL DEFLECTING DIAGNOSTIC/ABLATION CATHETER |
| Generic name | CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING |
| Applicant | Biosense Webster, Inc. |
| Product code | DRF |
| Received date | May 23, 2001 |
| Decision date | Jun 22, 2001 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: